Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Canopy Growth Corp T.WEED

Alternate Symbol(s):  T.WEED.DB | CGC

Canopy Growth Corporation is a cannabis company. It delivers innovative products with a focus on premium and mainstream cannabis brands, including Doja, 7ACRES, Tweed, and Deep Space, in addition to category-defining vaporizer technology made in Germany by Storz & Bickel. The principal activities of the Company are the production, distribution and sale of a diverse range of cannabis and cannabinoid-based products for both adult-use and medical purposes under a portfolio of distinct brands in Canada. Its Canada cannabis segment includes the production, distribution, and sale of a range of cannabis, hemp, and cannabis related products in Canada. International markets cannabis segment includes the production, distribution, and sale of a range of cannabis and hemp products internationally. Storz & Bickel segment includes the production, distribution, and sale of vaporizers. This Works segment includes the production, distribution and sale of beauty, skincare, wellness and sleep products.


TSX:WEED - Post by User

Bullboard Posts
Comment by Invest4Life2016on Jan 24, 2017 10:09pm
157 Views
Post# 25750604

RE:Bedrocan Now World’s First GMP-Approved Medicinal Cannabis

RE:Bedrocan Now World’s First GMP-Approved Medicinal Cannabis
EMH isn't too far behind in that department as well since they're all scientists first and foremost.  In a few weeks or less EMH is going to draw a lot of attention and considering they only have 22 million shares available to the public float it could get crazy here ;-)

Emerald Health Therapeutics Inc.

Emerald Health Therapeutics is a Licensed Producer under ACMPR, capable of cultivating and selling both dried medical cannabis flower and medical cannabis oils in Canada. Emerald operates out of a GMP-compliant indoor facility in Victoria, British Columbia, with plans for a 32 acre purpose built hybrid greenhouse expansion in metro Vancouver. Emerald prides itself on being one of Canada's most medically focused producers with amongst the most pharmaceutically qualified management teams in the industry. We aim to capture unique corners of both the medical and future recreational cannabis market through proprietary strains, defensible intellectual property, and superb patient and consumer experience.

 

VICTORIA, BC - January 24, 2017 (Investorideas.com Newswire) Emerald Health Therapeutics Inc. (TSXV: EMH) ("Emerald" or the "Company") is pleased to announce that management will present at Canaccord Genuity's inaugural Cannabis Investor Day on Thursday, January 26, 2017 at 3:10 p.m. Pacific Time. The conference will be taking place at the Fairmont Waterfront Hotel in Vancouver, BC.

"We believe cannabinoid medicines present an unparalleled opportunity for use as adjuvants (supplements) or replacements to a host of conventional pharmaceutical medicines that are typically much more toxic and potentially less efficacious. As an example, a therapeutic alternative to opiates. It's with that in mind that we remain focused on developing high quality cannabis-based medicines, backed by clinical efficacy, with standard dosing and conventional delivery mechanisms. We look forward to sharing this vision and participating in Canaccord Genuity's event," says Avtar Dhillon, M.D., Executive Chairman of Emerald.

For additional information on the event, please contact your Canaccord Genuity representative.

Join us on our journey of making lives better through cannabis science.

For more information, explore our website and investor presentation here (www.emerald.care/about)

ON BEHALF OF THE BOARD
Jim Heppell
Lead Director


Do your own DD
Bullboard Posts